A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
followed by successful engraftment. Grade 2 nausea and grade 1 emesis were seen briefly on day 2 of TMI. Skin erythema, oral mucositis, esophagitis, and enteritis were not observed. Conclusions: This report demonstrates the feasibility to selectively deliver myeloablative doses of radiation to bone and marrow using Tomotherapy. Organ doses were substantially lower than those associated with standard TBI and predict for the potential to significantly reduce associated toxicities, allowing fordoi:10.1016/j.bbmt.2005.11.284 fatcat:5u7as57cxrbwti2zjzrmx7eiw4